Skip to content

Clinical trials

Phase 2 Dermatitis, Atopic trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dermatitis, Atopic Phase: Phase 2 Country / region: United Kingdom Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20062
20081
20132
20153
20185
20194
20201
20212
20223
20232
20242
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Terminated6
Active, not recruiting5
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
LEO Pharma3
Novartis Pharmaceuticals3
Apogee Therapeutics, Inc.2
Astellas Pharma Inc2
Kymab Limited2
Regeneron Pharmaceuticals2
ACO Hud Nordic AB1
AbbVie1
Aerovance, Inc.1
Amgen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dermatitis, Atopic33
Eczema10
Dermatitis5
Pruritus3
Food Hypersensitivity1
Hypersensitivity1
Inflammation1
Lymphoma, Follicular1

Trials

Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.